Spyre Therapeutics (SYRE) Preferred Dividend Payments (2015)

Spyre Therapeutics (SYRE) posted Preferred Dividend Payments of $228000.0 for Q1 2015.

Spyre Therapeutics (SYRE) Preferred Dividend Payments (2015) Analysis & Trends

Spyre Therapeutics' Preferred Dividend Payments history runs 1 years deep, the most recent figure standing at $228000.0 for Q1 2015.

Quarterly Preferred Dividend Payments changed N/A year-over-year to $228000.0 in Q1 2015, while the trailing twelve-month figure through Dec 2015 was $228000.0 (changed N/A YoY) and the FY2015 annual result came in at $228000.0, changed N/A from the prior year.
Preferred Dividend Payments was $228000.0 for Q1 2015 at Spyre Therapeutics.
Across five years, Preferred Dividend Payments topped out at $228000.0 in Q1 2015 and bottomed at $228000.0 in Q1 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Pref Dividends (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Spyre Therapeutics	257.83 Mn	257.83 Mn	-	-

Download Data

Date	Value
Mar 31, 2015	228,000.00